Acumen Pharmaceuticals, Inc.
ABOS

$142.39 M
Marketcap
$2.37
Share price
Country
$-0.02
Change (1 day)
$5.09
Year High
$1.81
Year Low
Categories

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

marketcap

Stock price history for Acumen Pharmaceuticals, Inc. (ABOS)

Highest end of day price: $20.28 USD on 2021-07-02

Lowest end of day price: $1.86 USD on 2023-11-09

Stock price history of Acumen Pharmaceuticals, Inc. from 2021 to 2024